Overview of SQUARE pharmaceuticals LTD

This assignment has been produced to provide evidence of my organisations goals & objectives, the evidence provided gives clear distinction between the goals & objectives of my organisation.

The company's objective is to discharge the responsibility as leaders in its trade by acting with complete integrity, by carrying out its work to the public good and to the quality of life in the community, to provide unrivalled value to its customers in the quality of the goods it sells, in the competitiveness of its prices and in the range of choice it offers.

MEDA AB is an international specialty pharmaceutical organization with its headquarters set in Stockholm, Sweden. MEDA specializes is offering cost effective pharmaceuticals in areas such as respiratory, cardiology, dermatology, pain and inflammation, central nervous system (CNS), and over-the-counter (OTC) medicines (MEDA AB, 2012, p. 18). MEDA’s vision is to “become a world-leading specialty pharma company with a focus on sustainable and profitable growth to provide value for our patients, shareholders and other stakeholders” (MEDA AB, 2014, para. 1). MEDA is currently present in

Dr. Champion is a top notch drug specialist with a careful comprehension of drug store. In any case, following 33 years in business – an aggregate of about 60 years in drug store out and out – changes in the pharmaceutical

Americans must wait up to 19 years after a discovered treatment before they can participate in benefits of a new medication (Philipson & Sun, 2008). The regulatory process drug manufacturers need to endure before releasing potentially life-saving medication is an extremely expensive, time-consuming process. The Center for Drug Evaluation and Research (CDER) is the main department of the Food and Drug Administration (FDA) responsible for the safety of drugs (both prescription and over-the-counter) sold in the United States (Food and Drug Administration, 2011). This department scrutinizes the testing of new drugs and

The Medicines Company used the saying “one man’s trash is another man’s treasure,” to the next level. It essentially took what other pharmaceutical companies place on the shelves and never use again as their next product which becomes a money maker. The idea is a great idea if it is well executed. The company cannot take just any type of drug and try to execute it pouring in millions of dollars’ worth of research and development because if the product is not chosen carefully, the product will fail. A simple failure for a drug that was not carefully selected, can damage the company’s image and reputation.

Corporate social responsibility (CSR) refers to business practices involving initiatives that benefit society (2). CSR may also be referred to as "corporate citizenship" and can involve incurring short-term cost that do not provide an immediate financial benefit to the company, but instead promote positive social and environmental change(1).

Ceritinib (Zykadia) Novartis approved April 2014. FDA Rating: chemical type, NME (New Molecular Entity) and given P (priority review) status.1

The United States Pharmacopoeia (USP) was established to set the standards for the manufacture, nomenclature, indications, and chemical characteristics of drugs and continues to do so today. In 1938, the Pure Food and Drug Act created the FDA, to ensure the, “safety, efficacy, and appropriate labeling and advertising of pharmaceutical products before approving them for sale” (Blum, 2002). Prescription drugs are developed and both pre-clinical and

HPFB is national authority which regulates, evaluates and monitors the safety efficacy and quality of therapeutic and diagnostic products available to Canadians. These products consist of drug, medical devices, disinfectants and sanitizers with disinfectant claims. Further the HPFB reviews the clinical trial application and gives permission to distribute the information to investigators that are mentioned in application. The clinical trail application submitted to HPFB consist of information of dosage, production methods, preclinical results and information of investigators involved in conducting experiments. After these clinical tests are conducted on humans after successful results of clinical trials the sponsor can file for new drug submission, which will be discussed in Part D.

In an effort to make the most expensive and life saving biological drugs, more affordable and accessible to large population, under the act of “Affordable care Act” the U.S. Food and Drug Administration have approved Zarxio, the first biosimilar product in the United States.

Pharmaceutical organization that has gotten funding, enlisted a few different scientists, licensed the equation and built up its suitability in clinical tests. The company has received the endorsement of the US Food and Drug Administration (FDA) for this medication and the medicine can be obtained only by prescription. The product did exceptionally well even after not being able to infiltrate the business sector.

Based on these preclinical studies on animal, Merck submitted their Investigational New Drug (IND 65, 495) application to FDA was on August 2002.4

CORPORATE SOCIAL RESPONSIBILITY (CSR) is a term describing a company’s obligation to be accountable to all of its stakeholder in all its operation and activities. Socially responsible companies consider the full scope of their impact on communities and the environment when making decisions, balancing the needs of stakeholder with their need to make profit.

ISSN: 2277- 7695 TPI 2014; 3(7): 08-12 © 2013 TPI www.thepharmajournal.com Received: 14-08-2014 Accepted: 28-08-2014 Rizwan Raheem Ahmed Professor, Department of Business Administration & Commerce Indus University, Pakistan